Cisplatin Damage: Are DNA Repair Proteins Saviors or Traitors to the Cell?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  ChemBioChem

• Publication date

  2005-07-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cbic.200400427PMID 15934047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New Developments and Approaches in the Platinum Arena

  2012cited by this paper
• Cisplatin : chemistry and biochemistry of a leading anticancer drug

  2006cited by this paper
• The role of copper transporters in the development of resistance to Pt drugs.

  2004cited by this paper
• Identification of nuclear proteins that interact with platinum-modified DNA by photoaffinity labeling.

  2004cited by this paper
• Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions.

  2004cited by this paper
• Cisplatin Rapidly Down-regulates Its Own Influx Transporter hCTR1 in Cultured Human Ovarian Carcinoma Cells

  2004cited by this paper
• Adaptive Response in Embryogenesis: IV. Protective and Detrimental Bystander Effects Induced by X Radiation in Cultured Limb Bud Cells of Fetal Mice

  2004cited by this paper
• Two-dimensional Blue Native/SDS Gel Electrophoresis of Multi-Protein Complexes from Whole Cellular Lysates

  2004cited by this paper
• Radiation-induced bystander effects — implications for cancer

  2004cited by this paper
• A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells.

  2004cited by this paper
• Bystander Effects in Repair-Deficient Cell Lines

  2004cited by this paper
• Nature of full-length HMGB1 binding to cisplatin-modified DNA.

  2003cited by this paper
• Oxidative metabolism, gap junctions and the ionizing radiation-induced bystander effect

  2003cited by this paper
• Expression of CONNEXIN43 is highly sensitive to ionizing radiation and other environmental stresses.

  2003cited by this paper
• Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.

  2003cited by this paper
• Are There Mutator Polymerases?

  2003cited by this paper
• Poly(ADP-ribosyl)ation accelerates DNA repair in a pathway dependent on Cockayne syndrome B protein.

  2003cited by this paper
• A Novel Methionine-Based Signaling Mechanism Regulating the Expression of Thymidylate Synthase

  2003cited by this paper
• Genotoxic damage in non-irradiated cells: contribution from the bystander effect.

  2002cited by this paper
• DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis.

  2002cited by this paper
• Genomic instability and bystander effects: a paradigm shift in radiation biology?

  2002cited by this paper
• Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

  2002cited by this paper
• Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro

  2002cited by this paper
• Induction of Oct-3/4 expression in somatic cells by gap junction-mediated cAMP signaling from blastomeres.

  2002cited by this paper
• Bystander effects: intercellular transmission of radiation damage signals.

  2002cited by this paper
• Gap junction intercellular communication propagates cell death in cancerous cells

  2002cited by this paper
• Lighting up gap junction channels in a flash.

  2002cited by this paper
• Recognition of cisplatin adducts by cellular proteins.

  2001cited by this paper
• Connexin 26 Gene Therapy of Human Bladder Cancer: Induction of Growth Suppression, Apoptosis, and Synergy with Cisplatin

  2001cited by this paper
• DNA damage-induced mutagenesis : a novel target for cancer prevention.

  2001cited by this paper
• Current and future potential roles of the platinum drugs in the treatment of ovarian cancer.

  2001cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells.

  2001cited by this paper
• Kinetic Studies of the TATA-binding Protein Interaction with Cisplatin-modified DNA* 210

  2001cited by this paper
• Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery

  2001cited by this paper
• High and low fluences of alpha-particles induce a G1 checkpoint in human diploid fibroblasts.

  2000cited by this paper
• Enhanced sensitivity and long-term G2 arrest in hydrogen peroxide-treated Ku80-null cells are unrelated to DNA repair defects.

  2000cited by this paper
• Caught in the act: binding of Ku and PARP to MARs reveals novel aspects of their functional interaction.

  2000cited by this paper
• Poly(ADP-ribose) Binds to Specific Domains in DNA Damage Checkpoint Proteins*

  2000cited by this paper
• Human DNA polymerase kappa synthesizes DNA with extraordinarily low fidelity.

  2000cited by this paper
• Human DNA polymerase κ synthesizes DNA with extraordinarily low fidelity

  2000cited by this paper
• High and Low Fluences of α-Particles Induce a G1 Checkpoint in Human Diploid Fibroblasts

  2000cited by this paper
• DNA damage recognition during nucleotide excision repair in mammalian cells.

  1999cited by this paper
• Interactions of mammalian proteins with cisplatin-damaged DNA.

  1999cited by this paper
• Relative affinities of poly(ADP-ribose) polymerase and DNA-dependent protein kinase for DNA strand interruptions.

  1999cited by this paper
• The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

  1999cited by this paper
• Ku, a DNA repair protein with multiple cellular functions?

  1999cited by this paper
• Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

  1999cited by this paper
• Deficiency of connexin43 gap junctions is an independent marker for breast tumors.

  1999cited by this paper
• Suppression of the poly(ADP-ribose) polymerase activity by DNA-dependent protein kinase in vitro

  1999cited by this paper
• Replication Protein A (RPA) Binding to Duplex Cisplatin-damaged DNA Is Mediated through the Generation of Single-stranded DNA*

  1999cited by this paper
• Cisplatin inhibits synthesis of ribosomal RNA in vivo.

  1998cited by this paper
• Human replication protein A preferentially binds cisplatin-damaged duplex DNA in vitro.

  1998cited by this paper
• Stimulation of the DNA-dependent Protein Kinase by Poly(ADP-Ribose) Polymerase*

  1998cited by this paper
• TATA Binding Protein Discriminates between Different Lesions on DNA, Resulting in a Transcription Decrease

  1998cited by this paper
• Telomere loss in cells treated with cisplatin.

  1998cited by this paper
• UV sensitivity and impaired nucleotide excision repair in DNA-dependent protein kinase mutant cells.

  1998cited by this paper
• Studies of bystander effects in human fibroblasts using a charged particle microbeam.

  1998cited by this paper
• Palladated and platinated complexes derived from phenylacetaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cells. Formation of DNA interstrand cross-links by these complexes.

  1998cited by this paper
• Diverse functions of vertebrate gap junctions.

  1998cited by this paper
• Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis

  1997cited by this paper
• Cisplatin‐ and UV‐damaged DNA lure the basal transcription factor TFIID/TBP

  1997cited by this paper
• Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts.

  1997cited by this paper
• Mechanism of DNA-dependent protein kinase inhibition by cis-diamminedichloroplatinum(II)-damaged DNA.

  1997cited by this paper
• The major chromatin protein histone H1 binds preferentially to cis-platinum-damaged DNA.

  1997cited by this paper
• Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.

  1997cited by this paper
• Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells.

  1997cited by this paper
• Repair of cisplatin--DNA adducts by the mammalian excision nuclease.

  1996cited by this paper
• The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast.

  1996cited by this paper
• Requirement for Ku80 in growth and immunoglobulin V(D)J recombination

  1996cited by this paper
• Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential.

  1996cited by this paper
• Human Ku Autoantigen Binds Cisplatin-damaged DNA but Fails to Stimulate Human DNA-activated Protein Kinase*

  1996cited by this paper
• Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line*

  1996cited by this paper
• Catalytic activity of poly(ADP-ribose) polymerase is necessary for repair of N-methylpurines in nontranscribed, but not in transcribed, nuclear DNA sequences.

  1996cited by this paper
• The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin.

  1996cited by this paper
• DNA excision repair.

  1996cited by this paper
• The role of DNA mismatch repair in platinum drug resistance.

  1996cited by this paper
• Equilibrium model in an in vitro poly(ADP-ribose) turnover system.

  1995cited by this paper
• Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo.

  1995cited by this paper
• Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks.

  1995cited by this paper
• A novel form of Epstein-Barr virus latency in normal B cells in vivo.

  1995cited by this paper
• Binding of the Escherichia coli UvrAB Proteins to the DNA Mono- and Diadducts of cis-[N-2-Amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II) and Cisplatin

  1995cited by this paper
• Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.

  1995cited by this paper
• Enzymes acting at strand interruptions in DNA.

  1995cited by this paper
• Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

  1995cited by this paper
• HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

  1994cited by this paper
• Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis.

  1994cited by this paper
• Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).

  1994cited by this paper
• Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.

  1993cited by this paper
• Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin.

  1993cited by this paper
• Differential effects of cisplatin on the expression of chimeric marker genes in CV-1 cells.

  1992cited by this paper
• Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin.

  1992cited by this paper
• Cisplatin-induced imbalances in the pattern of chimeric marker gene expression in HeLa cells.

  1992cited by this paper
• An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts.

  1992cited by this paper
• Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.

  1991cited by this paper
• Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.

  1991cited by this paper
• Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.

  1990cited by this paper
• Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.

  1988cited by this paper
• Growth inhibition of transformed cells correlates with their junctional communication with normal cells.

  1986cited by this paper
• In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication.

  1985cited by this paper

• Slowing the reactivity of dicyclometalated Pd(II) complexes through the 2,6-bis(N-heterocyclic carbene)pyridine (C^N^C) non-leaving ligands: kinetic and computational study

  2024cites this paper
• Heterometallic bridged Pt(II)‐Zn(II) complexes: Influence of the substituent in 4′‐position in inert terpy ligand on antigenotoxicity, potential antitumor activity and mechanism of interactions of the complexes with biomolecules

  2024cites this paper
• Modes of Interactions with DNA/HSA Biomolecules and Comparative Cytotoxic Studies of Newly Synthesized Mononuclear Zinc(II) and Heteronuclear Platinum(II)/Zinc(II) Complexes toward Colorectal Cancer Cells

  2024cites this paper
• NIR light triggered intracellular polymerization via nanoparticles containing acrylates prodrugs and azo-polymers for inhibiting cisplatin efflux for combined chemotherapy and immunotherapy

  2023cites this paper
• Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles

  2023cites this paper
• The influence of electronic effects on the substitution reactions of N,N′-donor cis-palladium(II) complexes with bidentate (pyridin-2-yl)methyl-aniline ligands

  2023cites this paper
• Novel heterometallic Zn(II)-L-Cu(II) complexes: studies of the nucleophilic substitution reactions, antimicrobial, redox and cytotoxic activity

  2022cites this paper
• Osmium-Promoted σ-Bond Activation Reactions on Nucleosides

  2020cites this paper
• Controlling the reactivity of [Pd(II)(N^N^N)Cl]+ complexes using 2,6-bis(pyrazol-2-yl)pyridine ligands for biological application: Substitution reactivity, CT-DNA interactions and in vitro cytotoxicity study.

  2020cites this paper
• Novel heteronuclear Pt (II)‐L‐Zn (II) complexes: synthesis, interactions with biomolecules, cytotoxic properties. Two metals give promising antitumor activity?

  2020cites this paper
• Cytotoxic Effects of Plant Sap-Derived Extracellular Vesicles on Various Tumor Cell Types

  2020cites this paper
• Cisplatin: The first metal based anticancer drug.

  2019cites this paper
• Hsa_circ_0001946 Inhibits Lung Cancer Progression and Mediates Cisplatin Sensitivity in Non-small Cell Lung Cancer via the Nucleotide Excision Repair Signaling Pathway

  2019cites this paper
• Half‐sandwich Ruthenium (II) complexes with triphenylamine modified dipyridine skeleton and application in biology/luminescence imaging

  2019cites this paper
• Mechanistic insight on the chemistry of potential Pt antitumor agents as revealed by collaborative research performed in Kragujevac and Erlangen

  2019cites this paper
• The role of 8-quinolinyl moieties in tuning the reactivity of palladium(II) complexes: a kinetic and mechanistic study

  2019cites this paper
• Structures, hydrolysis, stabilities of palladium(II) complexes containing biologically active ligands and species distribution in aqueous solution

  2019cites this paper
• The anticancer effects and mechanisms of fucoxanthin combined with other drugs

  2019cites this paper
• Comparison of responsiveness to cancer development and anti-cancer drug in three different C57BL/6N stocks

  2019cites this paper
• Radicalic cleavage pathway and DNA docking studies of novel chemotherapic platinum agent of 5,6-di-2-ithienyl-2,3-dihydropyrazine

  2019cites this paper
• Interactions of binuclear copper(II) complexes with S-substituted thiosalicylate derivatives with some relevant biomolecules

  2019cites this paper
• Relative reactivity of N,N-donor ligands in substitution reactions of cis-diaqua(2-aminomethylpiperidine)platinum(II): a detailed kinetic and mechanistic study

  2018cites this paper
• Selective C8-Metalation of Purine Nucleosides via Oxidative Addition

  2018cites this paper
• Role of Protein Linked DNA Breaks in Cancer.

  2017cites this paper
• Cytotoxic platinum coordination compounds. DNA binding agents

  2017cites this paper
• Bis-picolinamide Ruthenium(III) Dihalide Complexes: Dichloride-to-Diiodide Exchange Generates Single trans Isomers with High Potency and Cancer Cell Selectivity.

  2017cites this paper
• Equilibrium and DFT studies of the bi- and mononuclear complexes of 4,4′-bipiperidine with Pd(2-(2-aminoethyl)-1-methylpyrrolidine) 2+ and other biorelevant ligands

  2017cites this paper
• How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs? An investigation combining μXRF and statistical analysis: Part I: On mice

  2016cites this paper
• ERCC1 Gene (C8092A) in Iranian Patients with Advanced Gastric Cancer Receiving Platinum-Based Chemotherapy

  2016cites this paper
• Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer Receiving Platinum-based Chemotherapy.

  2016cites this paper
• Palladium(II) complexes with highly basic imidazolin-2-imines and their reactivity toward small bio-molecules.

  2015cites this paper
• Substitution reactions of dinuclear platinum(II) complexes with some nitrogen nucleophiles

  2015cites this paper
• Kinetics, mechanism and equilibrium studies on the substitution reactions of Pd(II) in reference to Pt(II) complexes with bio-molecules

  2015cites this paper
• Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling

  2015cites this paper
• Kinetic and mechanistic studies of 1,3-bis(2-pyridylimino)isoindolate Pt(II) derivatives. Experimental and new computational approach.

  2014cites this paper
• A versatile methodology for the regioselective C⁸-metalation of purine bases.

  2014cites this paper
• Fucoxanthin Enhances Cisplatin-Induced Cytotoxicity via NFκB-Mediated Pathway and Downregulates DNA Repair Gene Expression in Human Hepatoma HepG2 Cells

  2013cites this paper
• CİSPLATİN DİRENCİNDE ETKİLİ MOLEKÜLER MEKANİZMALAR

  2013cites this paper
• Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms

  2013cites this paper
• The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro.

  2013cites this paper
• Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin

  2013cites this paper
• Roles of DNA polymerase eta and replication protein A (RPA) in undamaged and platinum-treated human cells

  2012influential citation
• Substitution behaviour of novel dinuclear Pt(II) complexes with bio-relevant nucleophiles.

  2012cites this paper
• The selective synthesis of metallanucleosides and metallanucleotides: a new tool for the functionalization of nucleic acids.

  2012cites this paper
• Structure-activity screening of platinum intercalators and molecular mechanisms for the cytotoxicity of 56MESS - [Pt(5,6-Dimethyl-Phen)(1S,2S-DACH)]²⁺

  2011cites this paper
• Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin

  2011cites this paper
• Copper Transporter 2 Regulates Endocytosis and Controls Tumor Growth and Sensitivity to Cisplatin In Vivo

  2011cites this paper
• Discrepancy between in vitro and in vivo antitumor effect of a new platinum(II) metallointercalator

  2011cites this paper
• Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity

  2011cites this paper
• Keimzelltumore und Cisplatinresistenz: Bildung von DNA-Addukten, Auswirkungen auf Zellzyklus und Zelltod und Beteiligung von DNA-Reparaturmechanismen

  2010influential citation
• Structural insight into dynamic bypass of the major cisplatin‐DNA adduct by Y‐family polymerase Dpo4

  2010cites this paper
• Structural insight into dynamic bypass of the major cisplatin-DNA adduct by Y-family polymerase Dpo 4

  2010cites this paper
• Functions of human DNA topoisomerases in cel proliferation and effects of anticancer drungs and natural compounds on the type II enzymes

  2010cites this paper
• Crystal structure of a cisplatin-(1,3-GTG) cross-link within DNA polymerase eta.

  2010cites this paper
• Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy

  2010cites this paper
• Cellular Responses to Cisplatin-Induced DNA Damage

  2010cites this paper
• Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.

  2010cites this paper
• Photoactivated Biological Activity of Transition‐Metal Complexes

  2010cites this paper
• Kristallstruktur eines Cisplatin‐(1,3‐GTG)‐Schadens im Komplex mit DNA‐Polymerase η

  2010cites this paper
• Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.

  2010cites this paper
• Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts

  2009cites this paper
• Role of copper transporters in resistance to platinating agents

  2009cites this paper
• New platinum and ruthenium complexes--the latest class of potential chemotherapeutic drugs--a review of recent developments in the field.

  2009cites this paper
• Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin

  2009cites this paper
• DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1α gene locus

  2009cites this paper
• Metallothioneins and platinum(II) anti-tumor compounds.

  2009cites this paper
• Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.

  2009cites this paper
• Influence of the chloride concentration on ligand substitution reactions of [Pt(SMC)Cl(2)] with biologically relevant nucleophiles.

  2009cites this paper
• Manganese(III)-salens induce tumor selective apoptosis in human cells.

  2009cites this paper
• Copper Transporter 2 (CTR2) as a regulator of cisplatin accumulation and sensitivity - eScholarship

  2009influential citation
• A detailed theoretical study of the interaction of thiourea with cis-diaqua(ethylenediamine) platinum(II)

  2009cites this paper
• Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

  2009cites this paper
• Equilibrium and Kinetic Studies of the Reactions between Aqua[1-(2-aminoethyl)piperazine]palladium(II) and Biologically Relevant Nucleophiles

  2009cites this paper
• Current Status and Future Perspectives of Platinum Antitumor Drugs

  2008cites this paper
• Resistance against novel anticancer metal compounds: differences and similarities.

  2008cites this paper
• Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy

  2008cites this paper
• Parameterization of azole‐bridged dinuclear platinum anticancer drugs via a QM/MM force matching procedure

  2008cites this paper
• Ruthenium porphyrin compounds for photodynamic therapy of cancer.

  2008cites this paper
• Kinetic studies on the reactions of [Pd(dach)(X-Y)] complexes with some DNA constituents.

  2008cites this paper
• Targeting DNA in therapies: using damages to design strategies on cell sensitisation

  2008cites this paper
• Targeting DNA in therapies: using damages to design strategies on cell sensitisation

  2008cites this paper
• DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer

  2008cites this paper
• Enhancement of Cisplatin [cis-Diammine Dichloroplatinum (II)] Cytotoxicity by O6-Benzylguanine Involves Endoplasmic Reticulum Stress

  2008cites this paper
• [Current status of and future perspectives for platinum antitumor drugs].

  2008cites this paper
• Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas

  2008cites this paper
• Mass spectrometric analysis of ubiquitin–platinum interactions of leading anticancer drugs: MALDI versus ESI

  2007cites this paper
• On the hydrolysis mechanism of the second-generation anticancer drug carboplatin.

  2007cites this paper
• NMR spectroscopy of anticancer platinum drugs.

  2007cites this paper
• Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

  2007cites this paper
• Molecular mechanisms of resistance and toxicity associated with platinating agents.

  2007cites this paper
• Direct cellular responses to platinum-induced DNA damage.

  2007cites this paper
• Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.

  2007cites this paper
• Kinetics and mechanism of the substitution reactions of [PtCl(bpma)]+, [PtCl(gly-met-S,N,N)] and their aqua analogues with l-methionine, glutathione and 5′-GMP

  2007cites this paper
• Azole-bridged diplatinum anticancer compounds. Modulating DNA flexibility to escape repair mechanism and avoid cross resistance.

  2007cites this paper
• Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands

  2007cites this paper
• Metal-ion-coordinating properties of the dinucleotide 2'-deoxyguanylyl(5'-->3')-2'-deoxy-5'-guanylate (d(pGpG)3-): isomeric equilibria including macrochelated complexes relevant for nucleic acids.

  2007cites this paper
• Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.

  2007cites this paper
• On the potential of thioredoxin reductase inhibitors for cancer therapy.

  2006cites this paper
• [Development, importance and perspectives. Tumor inhibiting metal compounds].

  2006cites this paper
• Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.

  2006cites this paper